Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $1.1 million.

  • bioAffinity Technologies' Shares Outstanding (Diluted Average) rose 15823.61% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 15823.61%. This contributed to the annual value of $12.1 million for FY2024, which is 3861.12% up from last year.
  • bioAffinity Technologies' Shares Outstanding (Diluted Average) amounted to $1.1 million in Q3 2025, which was up 15823.61% from $24.0 million recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Shares Outstanding (Diluted Average) peaked at $24.0 million during Q2 2025, and registered a low of $412936.0 during Q3 2024.
  • Moreover, its 4-year median value for Shares Outstanding (Diluted Average) was $8.6 million (2023), whereas its average is $8.6 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first surged by 21634.23% in 2023, then crashed by 9525.17% in 2024.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Shares Outstanding (Diluted Average) stood at $4.5 million in 2022, then surged by 94.43% to $8.7 million in 2023, then skyrocketed by 38.61% to $12.1 million in 2024, then tumbled by 91.21% to $1.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $1.1 million for Q3 2025, versus $24.0 million for Q2 2025 and $16.3 million for Q1 2025.